Elutia Inc. (ELUT) stock
ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/3011% below fair value
$0.81−0.02 (-2.41%)
Close on Nov 19, 2026Market cap $35.87MP/E –Yield –
Elutia free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Elutia's free cash flow for the twelve months ending Jun 30, 2026 was -$46.03M. For fiscal 2025 it was -$46.69M. The highest annual figure on record is -$7.80M in fiscal 2019.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$46.69M | – |
| FY2024 | Dec 31, 2024 | -$23.31M | – |
| FY2023 | Dec 31, 2023 | -$22.11M | – |
| FY2022 | Dec 31, 2022 | -$21.97M | – |
| FY2021 | Dec 31, 2021 | -$15.82M | – |
| FY2020 | Dec 31, 2020 | -$14.27M | – |
| FY2019 | Dec 31, 2019 | -$7.80M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$8.55M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.29M | – |
| Q4 FY2025 | Dec 31, 2025 | -$25.67M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.52M | – |
| Q2 FY2025 | Jun 30, 2025 | -$8.34M | – |
| Q1 FY2025 | Mar 31, 2025 | -$9.16M | – |
| Q4 FY2024 | Dec 31, 2024 | -$12.35M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.97M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.33M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.66M | – |
| Q4 FY2023 | Dec 31, 2023 | -$9.10M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.19M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.47M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.35M | – |
| Q2 FY2022 | Jun 30, 2022 | -$10.96M | – |
| Q1 FY2022 | Mar 31, 2022 | -$7.38M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.41M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.20M | – |
| Q2 FY2021 | Jun 30, 2021 | -$903.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.31M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.48M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.67M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.02M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.10M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.73M | – |
See a number that looks wrong?